Monopar Therapeutics, Inc. (MNPR)
57.75
+0.87
(+1.53%)
USD |
NASDAQ |
Feb 06, 16:00
57.71
-0.04
(-0.07%)
After-Hours: 20:00
Monopar Therapeutics Total Assets (Quarterly) : 144.20M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 18.67M |
| BioStem Technologies, Inc. | 62.39M |
| Iovance Biotherapeutics, Inc. | 904.95M |
| Protokinetix, Inc. | 0.4776M |
| GB Sciences, Inc. | 0.0945M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.639M |
| Shareholders Equity (Quarterly) | 141.56M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 56.10 |
| Net Debt Paydown Yield | -0.00% |